PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced that it will host a teleconference at 9 a.m. EST (6 a.m. PST) today to follow up on this morning’s press release announcing positive top-line Phase II data with Microcyn® Technology in mildly infected diabetic foot ulcers.
